Mario Sznol Selected Research

Vaccines

1/2018	A Serum Protein Signature Associated with Outcome after Anti-PD-1 Therapy in Metastatic Melanoma.
10/2011	Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mario Sznol Research Topics

Disease

97	Neoplasms (Cancer) 01/2024 - 01/2002
84	Melanoma (Melanoma, Malignant) 01/2024 - 01/2002
21	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 01/2002
13	Neoplasm Metastasis (Metastasis) 11/2023 - 05/2012
11	Disease Progression 08/2023 - 04/2014
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 06/2012
6	Fatigue 01/2021 - 05/2012
6	Brain Neoplasms (Brain Tumor) 01/2021 - 05/2012
6	Leukemia 01/2008 - 12/2003
4	Thrombocytopenia (Thrombopenia) 01/2017 - 01/2002
3	Carcinoma (Carcinomatosis) 01/2024 - 10/2022
3	Uveal melanoma 10/2023 - 03/2015
3	Kidney Neoplasms (Kidney Cancer) 01/2021 - 07/2008
3	Nausea 01/2017 - 01/2002
3	Leukopenia 01/2017 - 09/2003
3	Colitis 07/2016 - 07/2006
3	Hyperbilirubinemia 07/2006 - 01/2002
2	Edema (Dropsy) 01/2021 - 01/2019
2	Pneumonia (Pneumonitis) 09/2019 - 07/2016
2	Exanthema (Rash) 09/2019 - 05/2012
2	Lymphoma (Lymphomas) 01/2018 - 01/2017
2	Anemia 01/2017 - 01/2002
2	Inflammation (Inflammations) 03/2016 - 05/2012
2	Diarrhea 10/2013 - 01/2002
2	Body Weight (Weight, Body) 07/2013 - 06/2012
2	Nevus (Nevi) 09/2009 - 06/2006
2	Hematologic Neoplasms (Hematological Malignancy) 09/2007 - 12/2003
2	Mucositis 07/2006 - 09/2003
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2006 - 05/2004
2	Vomiting 09/2003 - 01/2002
1	Esophageal Neoplasms (Esophageal Cancer) 01/2024
1	Death (Near-Death Experience) 01/2024
1	Bites and Stings (Sting) 12/2023
1	Urologic Neoplasms (Urological Cancer) 10/2022

Drug/Important Bio-Agent (IBA)

35	NivolumabIBA 11/2023 - 07/2013
29	Immune Checkpoint InhibitorsIBA 01/2024 - 04/2014
23	IpilimumabIBA 11/2023 - 10/2011
15	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2009
14	AntibodiesIBA 01/2022 - 07/2005
9	bempegaldesleukinIBA 10/2023 - 01/2019
9	LigandsIBA 01/2022 - 06/2006
9	3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine)IBA 01/2017 - 09/2003
8	pembrolizumabIBA 01/2023 - 07/2016
8	Proteins (Proteins, Gene)FDA Link 11/2020 - 06/2006
8	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2017 - 07/2003
7	Interleukin-2 (IL2)IBA 01/2023 - 07/2008
7	AntigensIBA 11/2020 - 09/2009
6	B7-H1 AntigenIBA 12/2021 - 01/2014
6	atezolizumabIBA 12/2021 - 01/2016
6	Monoclonal AntibodiesIBA 10/2019 - 10/2011
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 09/2008
5	Bevacizumab (Avastin)FDA Link 12/2021 - 01/2016
5	CTLA-4 AntigenIBA 01/2017 - 10/2011
4	InterferonsIBA 12/2023 - 12/2005
4	RNA (Ribonucleic Acid)IBA 11/2023 - 06/2011
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023 - 12/2016
4	Programmed Cell Death 1 ReceptorIBA 01/2022 - 04/2012
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 01/2018
4	CytokinesIBA 11/2020 - 04/2012
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2023 - 11/2014
3	Cisplatin (Platino)FDA LinkGeneric 10/2022 - 01/2017
3	Alanine Transaminase (SGPT)IBA 01/2021 - 04/2015
3	Sunitinib (Sutent)FDA Link 01/2021 - 01/2018
3	Immunoglobulins (Immunoglobulin)IBA 06/2015 - 11/2014
3	VemurafenibIBA 05/2013 - 04/2010
3	Neoplasm Antigens (Tumor Antigens)IBA 10/2011 - 09/2009
3	laromustine (VNP40101M)IBA 11/2005 - 05/2004
3	Alkylating AgentsIBA 11/2005 - 05/2004
3	VNP 20009 (VNP20009)IBA 07/2005 - 01/2002
2	sotigalimabIBA 08/2023 - 01/2021
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2023 - 09/2008
2	Interleukin-12 (IL 12)IBA 01/2023 - 12/2005
2	Lipase (Acid Lipase)FDA Link 01/2022 - 04/2015
2	Immunomodulating AgentsIBA 12/2021 - 04/2012
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 05/2012
2	Adenosine (Adenocard)FDA LinkGeneric 01/2020 - 01/2008
2	cyclopropapyrroloindoleIBA 01/2020 - 01/2019
2	Transaminases (Aminotransferases)IBA 09/2019 - 07/2016
2	src-Family KinasesIBA 03/2019 - 05/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 07/2016
2	trametinibIBA 01/2018 - 11/2014
2	VaccinesIBA 01/2018 - 10/2011
2	dabrafenibIBA 01/2018 - 11/2014
2	Immunoglobulin G (IgG)IBA 09/2017 - 04/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 05/2013
2	ElectrolytesIBA 01/2017 - 01/2017
2	ChitinasesIBA 02/2015 - 05/2012
2	Cytotoxins (Cytolysins)IBA 11/2014 - 01/2007
2	Carboplatin (JM8)FDA LinkGeneric 05/2013 - 01/2007
2	Phosphotransferases (Kinase)IBA 04/2010 - 09/2009
2	DNA (Deoxyribonucleic Acid)IBA 01/2009 - 12/2003
2	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2006 - 11/2005
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	Axitinib (AG 013736)IBA 01/2023
1	avelumabIBA 01/2023

Therapy/Procedure

67	Therapeutics 01/2024 - 07/2005
34	Immunotherapy 01/2024 - 12/2004
9	Drug Therapy (Chemotherapy) 10/2022 - 07/2003
4	Aftercare (After-Treatment) 02/2023 - 09/2003
2	Intravenous Infusions 12/2003 - 01/2002